作者: A. M. Steward , D. Nixon , N. Zamcheck , A. Aisenberg
DOI: 10.1002/1097-0142(197405)33:5<1246::AID-CNCR2820330509>3.0.CO;2-O
关键词: Oncology 、 Hormonal therapy 、 Response to treatment 、 Breast cancer 、 Carcinoembryonic antigen 、 Disease progress 、 Medicine 、 Disease 、 Internal medicine 、 Primary cancer 、 Breast disease 、 Cancer research
摘要: Serum CEA was evaluated in 69 patients with breast cancer and 17 benign disease. elevated (above 2.5 ng/ml) 6 of 22 (27%) primary without clinical evidence distant metastases, 37 the 47 (79%) who had metastatic Sixteen (94%) cystic disease values less than ng/ml (1 2.9 ng/ml). Fourteen metastases undergoing chemo- hormonal therapy were studied by serial estimations for 3 to 18 months, a mean 14 months. The trends correlated response treatment.